![Профессор. Доктор. медицина. Флориан Гебауэр, [object Object]](/_next/image?url=https%3A%2F%2Fd3fzwscyjtgllx.cloudfront.net%2Fuploads%2Fimages%2F474316982625898561976.jpg&w=3840&q=60)
Директор хирургического центра Клиники общей и висцеральной хирургии
Консультирует в:
| 04/2021 | Extraordinary professorship, University of Cologne |
| 11/2016 | Habilitation & Venia legendi, University of Hamburg Title: Functional and prognostic significance of cell adhesion molecules in tumor progression of pancreatic cancer |
| 12/2010 | PhD, University of Hamburg (magna cum laude) Title: Prospective process analysis and pharmacoeconomic investigation of the Narcotrend monitor during cardiothoracic anesthesia. |
| 2020-today | Principal Investigator HOLIPANC Trial (Eudra-CT 2019-002734-37) Non-Randomised, Open Phase II Trial Investigating Efficacy, Safety and Quality of Life of Neoadjuvant Chemotherapy with Liposomal Irinotecan Combined with Oxaliplatin and 5 Fluorouracil/Folinic Acid Followed by Curative Surgical Resection in Patients with Hepatic Oligometastatic Adenocarcinoma of the Pancreas |
| 2014-2016 | Co-PI, Project coordinator, study design NEOPA-Trial (NCT01900327) Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma |
| 2015 | Investigator ESOLEAK (DRKS00007941) Endoscopic stenting vs. conservative treatment in patients with esophagogastric anastomotic insufficiency (German national study) |
| 2013-2014 | Investigator WOPP-Trial (NCT01855464) Pulmonary wedge resection plus parietal pleurectomy (WRPP) versus parietal pleurectomy (PP) for the treatment of recurrent primary pneumothorax |
| 2013 | Investigator Fibrocaps Study (NCT02284256) A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery |
German Society for General and Visceral Surgery (DGAV)
German Society for Surgery (DGCH)
German Society for Digestive and Metabolic Diseases (DGVS)
German Cancer Society (DKG)
Working Group for Internal Oncology (AIO)
